Regenxbio Inc (RGNX)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
488,498,000
EV to revenue ratio (TTM)
2.626
EV to ebitda
-3.372
Financial Performance
Revenue (TTM)
174,482,000
Gross profit (TTM)
-78,424,000
EBITDA
-148,776,992
Profitability
Operating margin (TTM)
27.10%
Profit margin
-112.60%
Return on assets (TTM)
-21.20%
Return on equity (TTM)
-137.60%
Per Share Metrics
Revenue per share (TTM)
3.34
EPS
-3.78
Diluted EPS (TTM)
-3.78
Book value
1.33
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
PEG ratio
0.26
Price to sales ratio (TTM)
2.8
Price to book ratio (TTM)
6.89
Growth
Quarterly earnings growth (YoY)
405.70%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
3
Buy
6
Hold
2
Sell
0
Strong sell
0
Risk & Volatility
Beta
0.933